The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acceleron Pharma Inc. | COM | 00434H108 | 7,748 | 188,602 | SH | SOLE | 188,602 | 0 | 0 | ||
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 49,429 | 1,672,714 | SH | SOLE | 1,672,714 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 56,767 | 2,726,568 | SH | SOLE | 2,726,568 | 0 | 0 | ||
| Alder BioPharmaceuticals, Inc. | COM | 014339105 | 18,670 | 1,586,220 | SH | SOLE | 1,586,220 | 0 | 0 | ||
| Epizyme, Inc. | COM | 29428V104 | 18,680 | 1,488,444 | SH | SOLE | 1,488,444 | 0 | 0 | ||
| Insmed Incorporated | COM | 457669307 | 24,460 | 955,462 | SH | SOLE | 955,462 | 0 | 0 | ||
| Twist Bioscience Corporation | COM | 90184D100 | 2,113 | 72,849 | SH | SOLE | 72,849 | 0 | 0 | ||